{"filing":{"accession_number":"0001628280-26-042525","cik":"0001396814","ticker":"PCRX","company_name":"Pacira BioSciences, Inc.","form":"8-K","filing_date":"2026-06-11","report_date":null,"primary_document":"pcrx-20260609.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1396814/000162828026042525/pcrx-20260609.htm"},"events":[{"id":5505,"run_id":4827,"accession_number":"0001628280-26-042525","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"Pacira BioSciences held its Annual Meeting of Stockholders on June 9, 2026, with detailed voting results disclosed for five proposals: election of three Class III directors (including contested nominees), ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and approval of two equity plans.","company_name":"Pacira BioSciences, Inc.","ticker":"PCRX","filing_date":"2026-06-11","submitted_at":null,"items":[{"id":6370,"accession_number":"0001628280-26-042525","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Pacira BioSciences' Annual Meeting held on June 9, 2026. The filing presents detailed vote tallies for five proposals: election of three Class III directors (including contested nominees from DOMA Perpetual Capital Management LLC), ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and approval of two equity plans. This is a quintessential Item 5.07 shareholder vote results disclosure that is material to investors assessing board composition and governance outcomes.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:35:20.995169+00:00","company_name":"","ticker":null,"filing_date":""},{"id":6371,"accession_number":"0001628280-26-042525","item_number":"8.01","item_title":"Other Events.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a press release issued on June 9, 2026 regarding the Company's Annual Meeting. While the Item 8.01 disclosure itself is sparse, the reference to an Annual Meeting press release strongly suggests disclosure of shareholder vote results, which is a material event. The actual vote results would be contained in Exhibit 99.1 (the press release), which is incorporated by reference.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:35:20.995169+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":5506,"run_id":4827,"accession_number":"0001628280-26-042525","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"summary":"Stockholders approved an Amended and Restated 2014 Employee Stock Purchase Plan (ESPP) with an increase of 800,000 newly reserved shares, a material compensatory arrangement affecting equity incentives available to employees.","company_name":"Pacira BioSciences, Inc.","ticker":"PCRX","filing_date":"2026-06-11","submitted_at":null,"items":[{"id":6369,"accession_number":"0001628280-26-042525","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses stockholder approval of an Amended and Restated 2014 Employee Stock Purchase Plan (ESPP) with an increase of 800,000 newly reserved shares, which is a material compensatory arrangement affecting equity incentives available to employees. While the section also includes routine committee reassignments, the ESPP amendment is the substantive material disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:35:20.995169+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":6369,"accession_number":"0001628280-26-042525","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses stockholder approval of an Amended and Restated 2014 Employee Stock Purchase Plan (ESPP) with an increase of 800,000 newly reserved shares, which is a material compensatory arrangement affecting equity incentives available to employees. While the section also includes routine committee reassignments, the ESPP amendment is the substantive material disclosure under Item 5.02(e).","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:35:20.995169+00:00","company_name":"Pacira BioSciences, Inc.","ticker":"PCRX","filing_date":"2026-06-11"},{"id":6370,"accession_number":"0001628280-26-042525","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from Pacira BioSciences' Annual Meeting held on June 9, 2026. The filing presents detailed vote tallies for five proposals: election of three Class III directors (including contested nominees from DOMA Perpetual Capital Management LLC), ratification of KPMG LLP as auditor, advisory vote on named executive officer compensation, and approval of two equity plans. This is a quintessential Item 5.07 shareholder vote results disclosure that is material to investors assessing board composition and governance outcomes.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:35:20.995169+00:00","company_name":"Pacira BioSciences, Inc.","ticker":"PCRX","filing_date":"2026-06-11"},{"id":6371,"accession_number":"0001628280-26-042525","item_number":"8.01","item_title":"Other Events.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses a press release issued on June 9, 2026 regarding the Company's Annual Meeting. While the Item 8.01 disclosure itself is sparse, the reference to an Annual Meeting press release strongly suggests disclosure of shareholder vote results, which is a material event. The actual vote results would be contained in Exhibit 99.1 (the press release), which is incorporated by reference.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-11T20:35:20.995169+00:00","company_name":"Pacira BioSciences, Inc.","ticker":"PCRX","filing_date":"2026-06-11"}]}